Péter Sandy

9.2k total citations · 1 hit paper
27 papers, 3.5k citations indexed

About

Péter Sandy is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Péter Sandy has authored 27 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Hematology. Recurrent topics in Péter Sandy's work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Péter Sandy is often cited by papers focused on Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related Molecular Pathways (5 papers). Péter Sandy collaborates with scholars based in United States, Italy and Germany. Péter Sandy's co-authors include Tyler Jacks, Louise Bergeron, Srividya Balasubramanian, Jennifer A. Mertz, Andrew R. Conery, Robert J. Sims, Barbara M. Bryant, Deanna A. Mele, Eric S. Lander and Sebastian Hoersch and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Péter Sandy

26 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting MYC dependence in cancer by inhibiting BET bromodomains

2011 876 citations Jennifer A. Mertz, Andrew R. Conery et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Péter Sandy United States	17	3.0k	994	629	429	273	27	3.5k
Yosef Landesman United States	33	2.5k 0.8×	935 0.9×	640 1.0×	303 0.7×	207 0.8×	171	3.2k
Marc R. Mansour United Kingdom	26	1.9k 0.6×	557 0.6×	651 1.0×	347 0.8×	191 0.7×	59	2.9k
Cassandra J. Vandenberg Australia	19	2.2k 0.7×	912 0.9×	301 0.5×	345 0.8×	265 1.0×	44	2.9k
Matty Verlaan–de Vries Netherlands	17	1.7k 0.6×	755 0.8×	294 0.5×	306 0.7×	166 0.6×	24	2.2k
Simona Ronzoni Italy	17	2.2k 0.7×	1.3k 1.4×	401 0.6×	659 1.5×	76 0.3×	29	3.2k
Olle Sangfelt Sweden	31	2.3k 0.8×	1.3k 1.3×	334 0.5×	553 1.3×	195 0.7×	51	3.4k
Mark A. Subler United States	32	2.0k 0.7×	1.5k 1.5×	197 0.3×	412 1.0×	323 1.2×	65	3.0k
William E. Pierceall United States	25	1.4k 0.5×	1.1k 1.1×	371 0.6×	351 0.8×	390 1.4×	55	2.5k
Kalindi Parmar United States	28	2.1k 0.7×	862 0.9×	706 1.1×	586 1.4×	68 0.2×	60	3.0k
Joseph M. Amann United States	28	1.8k 0.6×	825 0.8×	346 0.6×	426 1.0×	143 0.5×	53	2.7k

Countries citing papers authored by Péter Sandy

Since Specialization

Citations

This map shows the geographic impact of Péter Sandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Sandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Sandy more than expected).

Fields of papers citing papers by Péter Sandy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Sandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Sandy. The network helps show where Péter Sandy may publish in the future.

Co-authorship network of co-authors of Péter Sandy

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Sandy. A scholar is included among the top collaborators of Péter Sandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Sandy. Péter Sandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Lin, Meghana Kulkarni, Evan L. Chiswick, et al.. (2025). A novel approach for first‐in‐human dose selection using population dose–response modelling to find a minimum anticipated biological effect level. British Journal of Clinical Pharmacology. 91(9). 2555–2566.

Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations

Wong, Chung F., Saurabh V. Laddha, Laura H. Tang, et al.. (2014). The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors. Cell Death and Disease. 5(10). e1450–e1450. 50 indexed citations

Moros, Alexandra, Vanina Rodríguez, Ifigènia Saborit-Villarroya, et al.. (2014). Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 28(10). 2049–2059. 77 indexed citations

Nasveschuk, Christopher G., Alexandre Gagnon, Eric Y. Chan, et al.. (2013). Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth. Chemistry & Biology. 20(11). 1329–1339. 116 indexed citations

King, Bryan H., Thomas Trimarchi, Linsey B. Reavie, et al.. (2013). The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability. Cell. 153(7). 1552–1566. 252 indexed citations

Normant, Emmanuel, Richard Cummings, Steven F. Bellon, et al.. (2012). Abstract LB-237: In vitro and in vivo characterization of CPI-267203, a potent Inhibitor of bromodomain-containing proteins. Cancer Research. 72(8_Supplement). LB–237. 3 indexed citations

Cellurale, Cristina, Guadalupe Sabio, Norman J. Kennedy, et al.. (2011). Requirement of c-Jun NH ₂ -Terminal Kinase for Ras-Initiated Tumor Formation. Molecular and Cellular Biology. 31(7). 1565–1576. 84 indexed citations

Mertz, Jennifer A., Andrew R. Conery, Barbara M. Bryant, et al.. (2011). Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proceedings of the National Academy of Sciences. 108(40). 16669–16674. 876 indexed citations breakdown →

10.

Bjork, Bryan C., Yuko Fujiwara, Shannon W. Davis, et al.. (2010). A Transient Transgenic RNAi Strategy for Rapid Characterization of Gene Function during Embryonic Development. PLoS ONE. 5(12). e14375–e14375. 13 indexed citations

11.

Sandy, Péter, Sebastian Hoersch, Piyush B. Gupta, Tyler Jacks, & Eric S. Lander. (2009). AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer. DSpace@MIT (Massachusetts Institute of Technology). 430 indexed citations

12.

Scholl, Claudia, Stefan Fröhling, Ian F. Dunn, et al.. (2009). Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells. Cell. 137(5). 821–834. 416 indexed citations

13.

Kemp, Melissa L., et al.. (2007). Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production. Molecular Immunology. 44(12). 3085–3091. 11 indexed citations

14.

Nencioni, Alessio, et al.. (2004). RNA interference for the identification of disease-associated genes.. PubMed. 6(2). 136–40. 8 indexed citations

15.

Monte, Martín, Roberta Benetti, Giacomo Buscemi, et al.. (2003). The Cell Cycle-regulated Protein Human GTSE-1 Controls DNA Damage-induced Apoptosis by Affecting p53 Function. Journal of Biological Chemistry. 278(32). 30356–30364. 79 indexed citations

16.

Kanamori, Mutsumi, Péter Sandy, Stefania Marzinotto, et al.. (2003). The PDZ Protein Tax-interacting Protein-1 Inhibits β-Catenin Transcriptional Activity and Growth of Colorectal Cancer Cells. Journal of Biological Chemistry. 278(40). 38758–38764. 73 indexed citations

17.

Demarchi, Francesca, Cosetta Bertoli, Péter Sandy, & Claudio Schneider. (2003). Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability. Journal of Biological Chemistry. 278(41). 39583–39590. 138 indexed citations

18.

Sandy, Péter, Monica Gostissa, Valentina Fogal, et al.. (2000). p53 is involved in the p120E4F-mediated growth arrest. Oncogene. 19(2). 188–199. 39 indexed citations

19.

Gostissa, Monica, Arnd Hengstermann, Valentina Fogal, et al.. (1999). Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. The EMBO Journal. 18(22). 6462–6471. 426 indexed citations

20.

Saccone, Salvatore, Péter Sandy, Germana Meroni, et al.. (1998). Assignment<footref rid="foot01"><sup>1</sup></footref> of the E1A-regulated transcription factor E4F gene (E4F1) to human chromosome band 16p13.3 by in situ hybridization and somatic cell hybrids. Cytogenetic and Genome Research. 82(1-2). 99–100. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact